Beta-catenin modulator therapy(Kronos Bio)

N/A

Report date: 2023/12/29 16:53:21

Base Information

Drug NameBeta-catenin modulator therapy(Kronos Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 modulators
TargetsCatenin beta 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKronos Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKronos Bio Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A